Objectives Reported antioxidant, anti-inflammatory and neuroprotective properties for one aqueous-ethanolic extract from Thalassia testudinum which grows in the Caribbean Sea compelled us to explore about extract cytotoxic effects. Methods Cell viability was assayed on tumour (HepG2, PC12, Caco-2 and 4T1) and non-tumour (VERO, 3T3, CHO, MCDK and BHK2) cell lines. The extract effects upon primary cultures of rat and human hepatocytes and human lymphocytes were assayed. Key findings The extract exhibited cytotoxicity against cancer cells compared to normal cells, and the IC 50 values were 102 lg/ml for HepG2, 135 lg/ml for PC12, 165 lg/ml for Caco-2 and 129 lg/ml for 4T1 cells after 48 h, whereas IC 50 could not be calculated for normal cells. Additional data from a high-content screening multiparametric assay indicated that after 24-h exposure, the extract (up to 100 lg/ml) induced death in HepG2 cells through oxidative stress-associated mechanism, DNA damage and hypercalcaemia. Comet assay corroborated extract-induced DNA damage. Conclusions Thalassia testudinum extract is more cytotoxic and produced more DNA damage on human hepatoma cells than to other non-tumour cells. A possible mechanism is suggested for extract-induced cytotoxicity based on oxidative stress, nuclear damage and hypercalcaemia in HepG2 cells. T. testudinum may be a source for antitumour agents.
Introduction
Cancer is one of the leading causes of death in the world, and great interest arises in the search for new therapeutic agents because malignant cells use to develop resistance against anticancer drugs. Natural products and their derivatives are currently used as alternative in the treatment of various diseases, including cancer. [1] [2] [3] Bioactive natural products may exhibit beneficial effects over the whole body, and they usually induce less toxic effects than synthetic drugs. In particular, products from marine sources show interesting cytotoxic, antineoplastic and anticancer properties through the modulation of different molecular pathways. [4] Many of these products have been isolated from macro-organisms such as sponges, invertebrates, plants and seaweeds. [4] [5] [6] [7] Around twenty marine-derived drugs are currently under clinical trials, mostly in oncological therapy. [8] Cytotoxicity assays have been described as a primary and effective methodology to identify potential antitumour candidates. [9, 10] Cell viability tests complemented with other criteria for cell damage or toxicity and a careful interpretation of the results allow the identification of novel antitumour compounds in high-throughput screenings.
[11 This kind of approach has been used to identify new cytotoxic and antitumour products from natural sources including marine plants and seaweeds. [6, 7] The extract obtained from the marine angiosperm Thalassia testudinum, which grows abundantly in the Caribbean Sea, has demonstrated relevant pharmacological properties such as antioxidant, anti-inflammatory, cytoprotection and skin regeneration. [12] [13] [14] [15] Phytochemical characterisation showed that the extract is a complex mixture containing phenols, flavonoids, proanthocyanidins among others, [16] structures with recognised anticancer properties. Bioassay-guided fractionation resulted in the isolation of thalassiolin B, a sulphated flavone glycoside with strong antioxidant properties, [17] which has been reported to be at least in part responsible of the antioxidant properties described for the extract. [15] Phytochemical analysis also resulted in the isolation and identification of a new phenolic sulphate ester, along with seven phenolic derivatives not previously reported for this genus. [16] The findings suggest potential antitumour effects for T. testudinum aqueousethanolic extract.
Cytotoxicity is a well-known characteristic of many marine organism. [4] [5] [6] [7] However, the identification of new structures within this extract makes necessary to carry out proper evaluation of the extract toxicity effects upon different cell lines. The present study evaluated the cytotoxic capacity of T. testudinum aqueous-ethanolic extract against tumour and non-tumour cell lines. The possible intracellular mechanism involved in the observed effects was also explored in HepG2 cells.
Materials and Methods

Chemicals
Culture media and complements were purchased from GIBCO (Gibco BRL, Paisley, UK). Fluorescent probes Fluo-4 acetoxymethyl ester (Fluo-4 AM) were acquired from Molecular Probes, Invitrogen (Madrid, Spain); propidium iodide (PI), Hoechst 33342 and 2 0 ,7 0 -dichlorofluorescin diacetate (DCF-DA) were obtained from Sigma Aldrich (Madrid, Spain). TB was purchased from Santa Cruz Biotechnology Laboratories (USA). The other chemicals were purchased from Sigma Aldrich. [16, 17] The batch used in the present study contained various compounds previously identified, such as:
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0 -sulphate, chrysoeriol, apigenin; as well as the presence of proanthocyanidins as majority class and chrysoeriol-7-Ob-D-glucopyranosyl-2″-sulphate (Thalassiolin B, TB) ( Table 1 ). The structures of these compounds were established by spectroscopic (1D and 2D NMR) and spectrometric (HRMS) analysis and by comparing data with those reported in the literature.
Cell culture
Tumour (HepG2, PC12, Caco-2 and 4T1) and non-tumour cell lines (Vero, 3T3, CHO, J774 and BHK2) were provided by ATCC collection. They were cultured in Dulbecco's modified Eagle medium (DMEM), supplemented with glutamine 2 mM, antibiotic and 10% foetal bovine serum, according to the recommendations of the supplier. Cells Table 1 Chemical components in Thalassia testudinum extract [16] Components % AE SD were maintained in a 5% CO 2 atmosphere at 37°C in incubator.
Isolation and culture of lymphocytes
Human peripheral blood was obtained by venous puncture from healthy male voluntaries, no smokers, between 25 and 35 years old. Human peripheral blood lymphocytes were purified by Ficoll-Paque centrifugation according to the method of B€ oyum. [18] Afterwards, cells were resuspended, viability (>95%) was determined by the Trypan blue dye exclusion test and cell concentration was adjusted to 1 9 10 6 cells/ml.
Isolation and culture of hepatocytes
Rat hepatocytes were obtained from 200-300 g Sprague Dawley male rats by perfusion of the liver with collagenase as it has been previously described. [19] The study was approved by the Institutional Animal Ethics Committee in accordance with the guidelines of European Research Council for animal care and use. Human hepatocytes were isolated from small samples of the human liver tissue using a two-step perfusion technique as described in detail elsewhere. [20] Human liver samples were prepared from livers rejected for transplantation (i.e. prolonged cold ischaemic time, fibrosis, arteriosclerosis) under the supervision of the Hospital's Transplantation Coordination and in agreement with the rules of the hospital's Ethics Committee. None of the donors were suspected of harbouring any infectious disease, and all of them were negative for human immunodeficiency virus and hepatitis. None of the patients were habitual consumers of alcohol or other drugs.
After isolation, cellular viability was assessed by the Trypan blue dye exclusion test. Hepatocytes were seeded on fibronectin-coated 96-well plates or 3.5-cm-diameter dishes at a density of 8 9 10 4 viable cells/cm 2 in Ham's F-12/Lebovitz L-15 (1 : 1) medium supplemented with 2% calf serum, 0.2% bovine serum albumin, 50 mU/ml penicillin, 50 lg/ ml streptomycin and 10 nM insulin. Cells were incubated at 37°C in a 5% CO 2 humidified atmosphere. The medium was changed 1 h later to remove unattached hepatocytes, and 24 h later, cells were shifted to a serum-free culture medium supplemented with 10 nM dexamethasone and insulin.
Cytotoxicity evaluation
Cells were treated with different concentrations of T. testudinum extract (1-1000 lg/ml) or thalassiolin B (1-50 lg/ml) during 48 h, and cell viability was determined by MTT and neutral red assays, except for the lymphocytes which were evaluated by the Trypan blue dye exclusion test. Non-treated cells were used as control. The MTT ([3-4,5-dimethythiazol-2-yl]-2,5-diphenyltetrazolium bromide; Sigma, Madrid, Spain) reduction test was carried out as previously described. [21] The neutral red assay was performed according to the INVITOX Protocol. [22] After exposure to the extract, the percentage of cell viability was calculated in relation to non-treated cells (assumed as 100% value). The IC 50 was calculated from the concentration-effect curves as the concentrations causing a reduction of 50% in cell viability. All experimental series were done twice with three replicas for each determination.
Single cell gel electrophoresis (Comet assay)
DNA damage in human lymphocytes, hepatocytes and HepG2 cells was assessed by Comet assay. Cells were incubated with three concentrations of T. testudinum extract (10, 100 and 500 lg/ml) at 37°C during 1 h. After the exposure time, the culture medium was removed. Nontreated cells (medium-only) were used as negative control. Bleomycin (10 lg/ml) was used as positive control for lymphocytes and radiation gamma (2 Gy) for hepatic cells. DNA damage was evaluated in accordance with a previously described protocol. [23] Briefly, cells were prepared, embedded in agarose on a slide and lysed in a basic solution; slides were electrophoresed and stained with the silver staining kit. Finally, cells were visually scored according to the degree of DNA damage. Visual scoring was consistent with computer image analysis. Cells were scored on a scale of 1-5, where 1 represented an undamaged cell with intact DNA and no comet tail while 5 represented a highly damaged cell with a comet tail. Slides were blinded prior to scoring to prevent bias. [24] High-content screening multiparametric assay (HCS)
After 24-h exposure to increased concentrations of T. testudinum extract (10, 100, 500 and 1000 lg/ml) or thalassiolin B (1-50 lg/ml) at 37°C, HepG2 cells were washed and incubated with selected probes in order to measure multiple parameters indicative of cell toxicity. Cytosolic-free calcium concentrations were detected by using a Fluo-4 AM fluorescent probe; accumulation of the fluorescent compound 2 0 ,7 0 -dichlorofluorescin (DCF) was used as indicative of reactive oxygen species (ROS) generation. Cell viability was determined by propidium iodide (PI) exclusion, and Hoechst 33342 was used for cell count and detection of nuclear damage as described by Tolosa et al. [25] Fluorescent dyes were combined according to their optical compatibility in a flow cytometer. For each treatment, three independent wells were simultaneously incubated with 1.5 lg/ml PI, 1.5 lg/ml Hoechst 33342, 2 lg/ml DHCF-DA or 0.27 lg/ml Fluo-4 AM for 30 min.
After staining, samples were analysed with a Scan^R (Olympus), an HCS system based on automated epifluorescence microscopy and image analyses of cells in a microtiter plate format. The 109 objective was used to collect images for the different fluorescence channels. Nine fields per well were imaged and analysed using the Scan^R analysis module. Each measure was taken in individual cells and then averaged for the treatments. Results were expressed as a percentage of the corresponding parameter in the non-treated (control) cells (assumed as a 100% value).
Statistical analysis
The statistical analysis was performed by one-way ANOVA followed by the Dunnett's post hoc test for multiple comparisons using the GraphPad Prism 5 statistical software package. The values were expressed as mean AE standard deviation (SD), of at least three independent experiments, and the statistical significance P level used was 0.05.
Results and Discussion
Phenolics are recognised by their high structural diversity and broad spectrum of biological activities. They are increasingly looked upon as a valuable alternative or support for synthetic drugs which is evident by a growing number of clinical trials regarding the use of phenolic compounds and polyphenol-rich extracts in chemoprevention and therapy. [1] Here, the cytotoxicity of one aqueous-ethanolic extract from the marine angiosperm T. testudinum which grows in the Caribbean Sea and it is rich in this kind of structures was assayed in a panel of tumour and nontumour cells (Table 2) . Cell viability was determined using two individual methods based on different criteria, as it has been recommended. [11] This primary screening showed that under our experimental conditions, the exposure to different concentrations of T. testudinum extract up to 1000 lg/ml did not induce significant toxicity effects in normal cells, meanwhile above 100 lg/ml, the extract induced loss of cell viability in the tested tumour cell lines. These preliminary results indicated selective cytotoxicity of the aqueous extract towards the cancer cells. Thalassiolin B has been previously reported to be responsible in part for the bioactive properties of the extract, [12] [13] [14] [15] but no cytotoxic data has been reported so far. The present study showed that TB was not cytotoxic under our experimental conditions and IC 50 was higher than 50 lg/ml in all experimental series. TB contribution to the extract is 5.8% (Table 1) ; therefore, 50 lg/ml is about the bioavailable concentration of TB for 1000 lg/ml of the extract. These findings suggested the contribution of other components from the extract to the described cytotoxic effects, in particular, proanthocyanidins which are the major polyphenol specie (21%) ( Table 1) and it has been reported to exhibit antitumour properties. [26] [27] [28] This study also revealed that the human hepatoma HepG2 cell line was the most sensitive to the treatment with the extract (Table 2 ). The viability of HepG2 cells was reduced significantly in response to increasing concentrations of T. testudinum extract, while rat and human hepatocytes were unaffected by the treatment with the product (Figure 1) .
The IC 50 , derived from the MTT and other such assays, is an important first step in the detection of inhibitory 50 , represents the concentration of T. testudinum extract that inhibits the 50% of cell viability after 48-h exposure.
b ND, not determined. Cell viability for human lymphocytes was tested by Trypan blue dye exclusion assay. For these cells, after 48-h exposure, the cell viability was >85% between 10 and 1000 lg/ml. activity against tumour cells.
[11] Based on the IC 50 values, the extract did not seems to be highly cytotoxic. However, the best understanding of tumour biology has led to the identification of novel therapeutic targets which may act onto specific molecular events of this disease. These agents act specifically upon cancer cells lines at a reasonable concentration range, thus providing the possibility to use them in combination with currently therapeutic approaches in order to improve efficacy and to reduce side effects. [29] Therefore, in order to explore a possible mechanism underlying the cytotoxic effects of the extract, we evaluated the DNA damage in HepG2 cells in comparison to human hepatocytes and lymphocytes by single cell gel electrophoresis (Comet assay).
Our evaluation showed that T. testudinum extract causes DNA fragmentation and strain breaks (Figure 2) , suggesting DNA damage as the probable mechanism underlying the extract-induced cytotoxic effects. T. testudinum extract displayed a concentration-dependent DNA primary damage in human hepatoma cells, human hepatocytes and lymphocytes, but this effect was more pronounced in HepG2 cells, mainly at the concentration of 100 lg/ml (Figure 2a) . The extract exhibits DNA primary damage effects in hepatocytes and lymphocytes only at the highest concentration (500 lg/ ml), indicating selectivity for tumour cells (Figure 2b and  c) . DNA damage is a primary event which induces cell death mainly by apoptosis, activating the p53 pathway. [30, 31] The majority of the cytostatic drugs in clinical use at present are DNA-targeting agents which induce apoptotic cell death in vitro; however, their main drawback is the lack of selectivity for tumour cells, causing irreversible DNA damage and cell death also in normal healthy tissues. [11] Besides primary damage of DNA, we decided to evaluate other cellular effects caused by the extract and TB in HepG2 cells, through the HCS-multiparametric assay. TB, up to 50 lg/ml (TB represent the 5.8% of the extract) showed no cytotoxic effect, but T. testudinum extract did induce lost in cellular viability in HepG2 cells after 24-h exposure to 100-1000 lg/ml concentrations (Table 3) . This reinforced the hypothesis that TB alone is not responsible for the cytotoxicity effects observed for the extract. Other structures identified within the extract such as apigenin and chrysoeriol have been reported to exhibit anticancer effects. [16] Proanthocyanidins are well represented within the extract (21%, Figure 1 Concentration-response curves of the effect of Thalassia testudinum extract in the viability of HepG2 cells, human and rat hepatocytes. Cell viability was evaluated by MTT and neutral red assays after 48 h of exposure to the extract (1-1000 lg/ml) and the curves were represented using the mean of viability percentages calculated from both methods. The values are shown as mean percentages of control AE SD from six independent experiments. * represents P < 0.05 vs control (untreated cells). Figure 2 DNA damage induced by different concentrations of Thalassia testudinum extract (10, 100 and 500 lg/ml) in HepG2 cells, human hepatocytes and lymphocytes after 1-h exposure. The level of damage was measured through single cell gel electrophoresis (Comet assay). Cells treated during 1 h with 10 lM of bleomycine were used as a positive control for lymphocytes, while cells exposed for 30 s to 2 Gy of gamma radiation were used as the positive control for hepatocytes and the hepatoma cell line HepG2. Untreated cells were the negative control of the experiment. Values expressed as arbitrary units (AU) are the mean AE SD of at least three independent assays. *represents P < 0.05 vs the negative control. Table 1 ) and they have been reported to cause cell death by apoptosis on different cancer cell lines [32] [33] [34] by the same mechanism described above and they may contribute to the cytotoxic effects described here. Thus, the high content of diversified molecular scaffolds of phenolic nature may justify in a great extent the extract cytotoxic effects.
The extract also increased the amount of cytosolic Ca 2+ , stimulated the production of ROS, induced DNA fragmentation and nuclear damage and reduced the viability in a concentration-dependent fashion. These intracellular effects were consistent with a cytotoxic mechanism based on oxidative stress, nuclear damage and activation of cell death pathways.
It is well known that polyphenols exhibit strong antioxidant properties. Nevertheless, they may also act as pro-oxidants under certain cellular conditions. [35] [36] [37] In most of the cases, the mechanisms responsible for these effects have been related to the formation of ROS. [38, 39] Many cytotoxic products or small molecules display a similar mechanism in HepG2 and other cancer cell lines, inducing an oxidative stress-dependent cell death. [40] [41] [42] [43] For the majority of these cytotoxic effects, high intracellular levels of Ca 2+ seem to be a common factor. [40, 43] It has been described that free radicals induce the cytosolic accumulation of Ca 2+ by activation of voltage-sensitive membrane channels or disruption of membrane integrity of mitochondria and endoplasmic reticulum, which are the main Ca 2+ stores within the cell. [45] [46] [47] Elevated intracellular Ca 2+ is recognised as a signal of cell injury and cytotoxicity, increasing the ROS generation and causing metabolic and energetic imbalances which may lead to cell death by necroptosis or apoptosis. [44, 46, 48, 49] In addition, this ion activates kinases, phospholipases, endonucleases, proteases and caspases, which are directly involved in different cell death pathways. [50] [51] [52] Further research could be necessary to elucidate the type of cell death induced by T. testudinum extract in HepG2 and to explore its effects to other cancer cell lines, but present results suggest a cytotoxic mechanism based on oxidative stress, DNA damage and hypercalcaemia. In addition, a deeper characterisation of the antitumour mechanisms of T. testudinum extract will provide more insights into this issue.
Conclusions
In summary, this work provided evidence of the cytotoxic and DNA damage potential of T. testudinum specie and highlighted the effects of T. testudinum aqueous-ethanolic extract on human hepatoma cells in comparison to other non-tumour cells. It also revealed a possible mechanism for T. testudinum extract-induced cytotoxicity based on oxidative stress, nuclear damage and sustained hypercalcaemia, at least in HepG2 cells. Our data suggested that T. testudinum extract or its derivates may be further explored to develop novel natural anticancer drugs.
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